Structure and regulation of mammalian squalene synthase

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1529, Issue 1-3, 2000, Pages 49-62

  Tansey, Terese R ^a   Shechter, Ishaiahu ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cholesterol biosynthesis; Cytokine; Isoprenoid metabolism; Squalene synthase; Sterol regulatory element binding protein

Indexed keywords

ASPARTIC ACID; CHOLESTEROL; CYTOKINE; INTERLEUKIN 1BETA; ISOPRENOID; MESSENGER RNA; MEVINOLIN; PHENYLALANINE; PROTEIN; SQUALENE SYNTHASE; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME STRUCTURE, FUNCTION AND VARIABILITY; ENZYME SUBSTRATE COMPLEX; GENETIC TRANSCRIPTION; HUMAN; MAMMAL; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REACTION ANALYSIS; REGULATORY MECHANISM; REVIEW; SITE DIRECTED MUTAGENESIS; STEROL SYNTHESIS; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHOLESTEROL; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KINETICS; LIVER; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); SQUALENE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

MAMMALIA;

EID: 0034672674     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00137-2     Document Type: Review

References (91)

1. The mechanism of the condensation reactions of cholesterol biosynthesis
2. Biosynthesis of non-head-to-tail terpenes: formation of 1'-1 and 1'-3 linkages
3. Squalene synthase: structure and regulation
4. Regulation of the mevalonate pathway
5. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth
6. Solubilization, purification, and characterization of a truncated form of rat hepatic squalene synthetase
7. Subcellular localization of squalene synthase in rat hepatic cells. Biochemical and immunochemical evidence
8. Squalene synthetase. 3. Mechanism of the reaction
9. Purification to homogeneity and some properties of squalene synthetase
10. Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae
11. The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae
12. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase
13. Squalene synthase inhibitors: their potential as hypocholesterolaemic agents
14. Squalene synthase inhibitors
15. Sulfobetaine zwitterionic inhibitors of squalene synthase
16. 3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors
17. Yeast squalene synthase. A mechanism for addition of substrates and activation by NADPH
18. Mechanism of inhibition of yeast squalene synthase by substrate analog inhibitors
19. Squalene synthetase. Inhibition by ammonium analogs of carbocationic intermediates in the conversion of presqualene diphosphate to squalene
20. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells
21. Squalene synthase: steady-state, pre-steady-state, and isotope-trapping studies
22. Carotenoids 2: Genetics and molecular biology of carotenoid pigment biosynthesis
23. Carotenoid biosynthesis: Isolation and characterization of a bifunctional enzyme catalyzing the synthesis of phytoene
24. Molecular cloning and expression in Escherichia coli of a cyanobacterial gene coding for phytoene synthase, a carotenoid biosynthesis enzyme
25. Light-dependent regulation of carotenoid biosynthesis occurs at the level of phytoene synthase expression and is mediated by phytochrome in Sinapis alba and Arabidopsis thaliana seedlings
26. Molecular cloning and characterization of the yeast gene for squalene synthetase
27. Isolation and primary structure of the ERG9 gene of Saccharomyces cerevisiae encoding squalene synthetase
28. Molecular cloning, expression, and characterization of the cDNA for the rat hepatic squalene synthase
29. Conservation between human and fungal squalene synthetases: similarities in structure, function, and regulation
30. Cloning, expression and characterization of the cDNA encoding human hepatic squalene synthase, and its relationship to phytoene synthase
31. Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems
32. Chain elongation in the isoprenoid biosynthetic pathway
33. Creating isoprenoid diversity
34. Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-A resolution
35. Crystal structure of pentalenene synthase: mechanistic insights on terpenoid cyclization reactions in biology
36. Structural basis for cyclic terpene biosynthesis by tobacco 5-epi-aristolochene synthase
37. Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity
38. Yeast farnesyl-diphosphate synthase: site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II
39. Function-structure studies and identification of three enzyme domains involved in the catalytic activity in rat hepatic squalene synthase [published erratum appears in J. Biol. Chem. 273 (1998) 17296]
40. Regulation of product chain length by isoprenyl diphosphate synthases
41. Cation-pi interactions in chemistry and biology: a new view of benzene. Phe, Tyr, and Trp
42. The structure of the membrane protein squalene-hopene cyclase at 2.0 A resolution
43. Crystal structure of human squalene synthase
44. Transcriptional regulation by lovastatin and 25-hydroxycholesterol in HepG2 cells and molecular cloning and expression of the cDNA for the human hepatic squalene synthase
45. Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor
46. Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins
47. Effects of endotoxin and cytokines on lipid metabolism
48. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters
49. Discordant regulation of proteins of cholesterol metabolism during the acute phase response
50. Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters
51. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
52. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis
53. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
54. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans
55. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene
56. Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein
57. Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y
58. A critical role for cAMP response element-binding protein (CREB) as a co-activator in sterol-regulated transcription of 3-hydroxy-3-methylglutaryl coenzyme A synthase promoter
59. YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes
60. Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the Yin Yang 1 protein
61. Molecular cloning and functional analysis of the promoter of the human squalene synthase gene
62. Multiple sequence elements are involved in the transcriptional regulation of the human squalene synthase gene
63. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a
64. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells
65. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein
66. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver
67. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2
68. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats
69. ADD-1 provides major new insight into the mechanism of insulin action
70. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes
71. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
72. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus
73. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene
74. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL
75. Differential transcriptional regulation of the human squalene synthase gene by sterol regulatory element-binding proteins (SREBP) 1a and 2 and involvement of 5' DNA sequence elements in the regulation
76. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells
77. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver
78. Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2
79. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
80. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment
81. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver
82. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase
83. The physiological role of sterol regulatory element-binding protein-2 in cultured human cells
84. Molecular cloning and functional expression of a cDNA for mouse squalene synthase
85. Localization of the squalene synthase gene (FDFT1) to human chromosome 8p22-p23.1
86. Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes [published erratum appears in J. Lipid. Res. 37 (1996) 2269]
87. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase